CompletedPhase 3Phase 4ACTRN12605000556640

Seroquel compared to Risperidone in the treatment of psychotic disorders adolescents.

Randomised controlled clinical trial of the efficacy and tolerability of Seroquel compared to Risperidone in the treatment of psychotic disorders among 15-18 year old adolescents.

Sponsor

Dr Harith Swadi

Enrollment

60 participants

Start Date

Jun 1, 2003

Study Type

Interventional

Conditions

Adolescent psychosis

Summary

The purpose of this study is to determine if treatment with quetiapine will improve young patients psychosis.

Eligibility

Sex: Both males and femalesMax Age: 19 Yearss

Plain Language Summary

Simplified for easier understanding

This is a research study looking at: Seroquel compared to Risperidone in the treatment of psychotic disorders adolescents.. It may be open to adults up to age 19. Key requirements include: Provision of written informed consent. Participation typically involves medical assessments and follow-up visits as part of the research.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Quetiapine fumarate (titrate to between 400 and 800mg) Risperidone (titrated to between 4-6mg)

Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000556640